New CMS Accountable Care Model Expected to Benefit Value-Based Care Providers
New ACO Model Introduction: CMS has announced the Long-term Enhanced ACO Design (LEAD) model, a 10-year voluntary pilot program starting in 2027, aimed at improving value-based care for healthcare providers.
Improvements Over Previous Model: LEAD addresses financial and administrative challenges faced by providers, offering enhanced cash flow payments and tools to better meet patient needs, particularly for high-needs patients.
Positive Industry Reaction: Jefferies has responded favorably to the LEAD model, indicating it provides future flexibility and stability for value-based care within Medicare fee-for-service.
Supporting Companies: Companies like Astrana Health, agilon health, and Privia Health Group are involved in supporting ACOs, with recent developments in their financial standings and market positions.
Get Free Real-Time Notifications for Any Stock
Analyst Views on AGL
About AGL
About the author

Agilon Health Faces Class Action Lawsuit Notification
- Class Action Initiation: Levi & Korsinsky LLP has notified investors that Agilon Health, Inc. (NYSE: AGL) is facing a class action lawsuit for alleged securities fraud, with the lawsuit covering the period from February 26, 2025, to August 4, 2025, aimed at recovering losses for affected investors.
- False Statement Allegations: The complaint alleges that the defendants recklessly issued guidance for 2025 despite being aware of significant industry headwinds, and materially overstated the positive financial impact of 'strategic actions' taken by Agilon, resulting in misleading statements about the company's business and prospects.
- Investor Rights Protection: Affected investors have until March 2, 2026, to apply to be appointed as lead plaintiff to share in any recovery, with no out-of-pocket costs or fees required to participate, thereby lowering the barrier for investor involvement in the lawsuit.
- Law Firm Background: Levi & Korsinsky has over 20 years of experience in securities litigation, having secured hundreds of millions for aggrieved shareholders, and has been ranked among the top securities litigation firms in the U.S. for seven consecutive years, demonstrating its expertise in complex securities cases.

Faruqi & Faruqi Investigates Securities Fraud at agilon health
- Legal Investigation Launched: Faruq & Faruqi LLP is investigating potential securities fraud claims against agilon health, focusing on investor losses incurred between February 26 and August 4, 2025, indicating significant legal risks for the company.
- Financial Guidance Missteps: The lawsuit alleges that agilon health executives recklessly issued guidance for 2025 that they knew was unattainable due to known industry headwinds, resulting in substantial investor losses and highlighting governance failures within the company.
- Stock Price Plunge: Following the announcement to suspend its 2025 financial guidance, agilon health's stock plummeted by 51.5% on August 5, 2025, reflecting severe market concerns regarding the company's financial health.
- Investor Rights Protection: Faruq & Faruqi encourages investors to be aware that March 2 is the deadline to apply as lead plaintiff in the class action, emphasizing the importance of protecting investor rights.









